|
Dr. Randall S. Moore
CEO
Randall S. Moore, MD, MBA is a highly regarded visionary and leader in the world of business, medicine and healthcare. His experience includes more than 20 years working as both a physician and an executive in the medical industry, with a focus on system level change, integrating advanced business and clinical models. Most recently, Moore managed his own consulting firm helping clients such as Pfizer, The Zitter Group, Novartis and Protocare Sciences with new business development, disease management, managed care application and board management. He also was a senior vice president of Integrated Medical Development for MedPartners; and served as Caremark International1s Vice President and Chief Medical Officer. His responsibilities included clinical research, medical informatics, disease management, clinical reengineering, and new business development. Dr. Moore's work has included medical writing, numerous presentations at medical and scientific meetings, and board development and membership, including serving on the board of a 800,000 member health plan.
Moore graduated with AOA honors from Johns Hopkins School of Medicine, before completing his training in internal medicine at the University of Minnesota, where he served on the faculty for 9 years. His education also includes study at the University of London, and earning his MBA from the Kellogg Graduate School of Management at Northwestern University.
Allen U. Lenzmeier
Chairman
Director since September 2008, is Vice Chairman and a director of Best Buy Co., Inc. (NYSE:BBY) and currently assists Best Buy on a part-time basis. Mr. Lenzmeier joined Best Buy in 1984 and prior to his appointment as Vice Chairman in 2004, he served the company for more than 20 years in various capacities: Vice President of Finance Operations, Executive Vice President and Chief Financial Officer, President of Best Buy Retail Stores, and President and Chief Operating Officer.
Mr. Lenzmeier serves on the board of directors of UTStarcom, Inc. (NASDAQ:UTSI) and on the boards of several private companies. In addition, Mr. Lenzmeier is a national trustee for the Boys and Girls Clubs of America and serves on its Twin Cities board in Minnesota. He holds a bachelor’s of science degree from Minnesota State University, Mankato.
R. Edward Bergmark
Bio coming soon.
Kenneth D. Bloem, M.P.H.
Named a director on March 9, 2004. Mr. Bloem is an independent consultant who focuses on healthcare, education and small business ventures. Mr. Bloem is a member of the Board of Directors of the Hamad Medical Corporation (the national health services delivery system for the nation of Qatar), and he also serves on the boards of several for profit, privately held health companies in the United States. He is a member of the American Hospital Association’s Ad Hoc Committee on Payment for Health Services and an Adjunct Associate Professor of International Health at the Boston University School of Public Health. Mr. Bloem recently served as a Senior Fellow at the Johns Hopkins Center for Civilian Biodefense Strategies and as Senior Fellow for the Association of Academic Health Centers.
Prior to establishing his consulting practice, Mr. Bloem was the CEO of Stanford University Hospital, Georgetown University Medical Center and the Advisory Board Company. He has also held leadership positions at the University of Chicago Hospitals and Boston University Medical Center. A former Peace Corp volunteer (Malawi and Congo) and epidemiologist for the World Health Organization, Mr. Bloem is a recipient of several honors and awards, including the World Health Organization’s “Order of the Bifurcated Needle” for contributions to global smallpox eradication. Mr. Bloem is a graduate of Calvin College (Grand Rapids, MI) and holds a master’s of science in public health from the Harvard School of Public Health.
David B. Kaysen
Director since 2001, is President, Chief Executive Officer and a director of Uroplasty, Inc. (OTCBB: UPI). Previously, Mr. Kaysen served as President, Chief Executive Officer and a director of Advanced Duplications Services, LLC, a privately-held replicator and duplicator of optical media. From December 2002 - June 2005, he served as President, Chief Executive Officer and a director of Diametrics Medical, Inc. (OTCBB:DMED), a manufacturer and marketer of critical care blood analysis systems that provide continuous diagnostic results at point of care. From 1992 to 2002, Mr. Kaysen was the Chief Executive Officer, President and a director of Rehabilicare Inc. (NASDAQ:REHB), since renamed Compex Technologies, Inc., a marketer of electromedical rehabilitation and pain management products. From 1989 to 1992, Mr. Kaysen served as Executive Vice President for Emeritus, a clinical assessment software company for the nursing home industry. From 1988 to 1989 he served as President and CEO and he continues to serve as a director of Surgidyne, Inc., a specialty medical surgical products company, and from 1986 to 1988 he was Vice President of Marketing for Red Line/XVIIIB Medimart, a medical/surgical product distributor to the nursing home industry.
Mr. Kaysen also currently serves on the boards of MedicalCV, Inc. (OTCBB:MCCVU:OB) and Zevex International (NASDAQ:ZVXI). He holds a bachelor’s of science in business administration from the University of Minnesota, Minneapolis.
Joseph J. McErlane
Director since September 2008, Mr. MacErlane has more than 35 years of experience in the employee benefits industry. Mr. McErlane was one of the founders of National Benefit Resources and led the company through its acquisition by UnitedHealth Group (NYSE:UNH) in 1999. He continued as Chairman and Chief Executive Officer of National Benefit Resources until 2004 and then served in an advisory capacity through 2006. Prior to founding National Benefit Resources 1984, Mr. McErlane was Vice President of Group Sales for the IDS Life Insurance Company.
Mr. McErlane previously served as a board member of the Self Insurance Institute of America (SIIA) and now serves as a director of Asset Recovery Corporation and NeoPath Health, LLC. He holds a bachelor’s of arts degree from Villanova University.
Michael O’Sullivan, M.D.
Director since September 2002, was most recently Chair of the Board of Governors at Mayo Clinic Scottsdale. His background includes 27 years as a physician leader at Mayo Clinic. Prior to moving to the Scottsdale Clinic in 1997, he led the development of Mayo Medical Laboratories, an internationally renowned medical reference laboratory. Dr. O’Sullivan was the first physician leader of Mayo Medical Ventures, the health information and technology transfer arm of Mayo. From 1992 to 1997, he led the development of the regional Mayo Health System in Minnesota, Wisconsin and Iowa that now includes some 400 physicians and eight hospitals in 42 communities. In addition, Dr. O’Sullivan served for 13 years as a member of the Mayo Foundation Board of Trustees and two terms on the Mayo Clinic Rochester Board of Governors.
Dr. O’Sullivan is a past president of the Academy of Clinical Laboratory Physicians and Scientists and is a U.S. Air Force veteran. He holds an M.D. from the National University of Ireland, Cork, Ireland.
C.A. (Lance) Piccolo
Director since March 2003, has served as President and Chief Executive Officer of HealthPic Consultants, Inc., a strategic healthcare consulting firm, since September, 1996. Mr. Piccolo currently serves as a director on the boards of CVS Caremark (NYSE:CVS), the nation’s largest provider of prescriptions and related healthcare services, Chemtura Corporation, a polymer and specialty products manufacturer, and NovaMed Eyecare, Inc. (NASDAQ:NOVA), an eye care services company. From August 1992 until September 1996, he was Chairman of the Board and Chief Executive officer of Caremark International Inc. (NYSE:CMX) a provider of physician practice management, pharmacy benefit management and disease management services. Mr. Piccolo previously served as vice chairman of the board of Caremark Rx, Inc. from 2004 until the closing of the CVS Caremark merger, when he became a director of CVS Caremark.
Mr. Piccolo serves on the board of trustees of the University of Chicago Hospitals and on the advisory board of the Kellogg Graduate School of Management, Northwestern University. He has a bachelor’s of science degree from Boston University.
|
Company Officers
Michael C. Chappuis
President and Chief Operating Officer
Mike joined American TeleCare in 2004 with 20 years of executive experience in operations, supply chain management and FDA Class II/III medical device development and manufacturing. Before coming to ATI, he was Vice President of Operations for Virtucom Content Solutions, Inc. He has also served as Vice President of Supply Chain Connectivity for HealthNexis, LLC, a venture founded by leading medical product manufacturers and distributors to improve health care supply chain efficiencies. Mike’s previous experience also includes six years with InnoMedica / Innovex, Inc., an FDA Class II/III medical products manufacturer, where he started in 1990 as Engineering Manager and completed his service with the company as Vice President and General Manager. He was awarded patents for an FDA Class III miniaturized pacing lead and a surgical clamping device for single-hand use. Mike began his career with engineering positions at Control Data and Martin Marietta. He holds a bachelor’s of science in aerospace engineering and mechanics from the University of Minnesota.
Mike Brodeur
Chief Financial Officer
Mike is a seasoned executive with more than 25 years of high-level financial management experience in the health care, medical device, biotechnology and clinical laboratory industries. Immediately before joining ATI in 2009, he was the CFO of Medical CV, Inc., developer and manufacturer of laser-based surgical devices. He has also served as CFO of McKesson Medical Management (a $500 million pharmacy outsource provider to hospitals) and Meris Laboratories, Inc. (a $50 million clinical laboratory testing company). Mike previously held other senior financial leadership positions with EPS Solutions Corporation and WellPoint Health Networks, Inc., now WellPoint, Inc., which today is the nation’s largest health insurer by member numbers. He was a managing partner at Prairieview CFO Partners, LLP, a CFO services firm for public and pre-IPO emerging and middle-market businesses. And as senior partner at Tatum CFO Partners, LLP, another national CFO services firm, he served as CFO of Molecular Diagnostics, Inc., now CytoCore, Inc. and Aastrom Biosciences, Inc.
Mike is a certified public accountant and began his career at Ernst & Young. He earned a bachelor’s of science degree in business administration and accountancy at California State University, Long Beach, Calif.
|
